Website
N/ATelephone
61.7.3152.3200
Address
Suite 302, Level 3 9 Sherwood Road Toowong Tower Toowong, Queensland (QLD) 4066
Description
Anteris Technologies Ltd. is a structural heart company, researches, develops, commercializes, and distributes various medical technologies and devices. It manufactures, distributes, and sells ADAPT & DurAVR regenerative tissue products, and researches and develops regenerative medicine and immunotherapies. The company was founded on June 23, 1999 and is headquartered in Toowong, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 18.05 - 26.99
Trade Value (12mth)
AU$68,540.00
1 week
-2.99%
1 month
-2.74%
YTD
-9.93%
1 year
-15.22%
All time high
186.884
EPS 3 yr Growth
236.500%
EBITDA Margin
-994.40%
Operating Cashflow
-$39m
Free Cash Flow Return
-272.30%
ROIC
-309.70%
Interest Coverage
-47.20
Quick Ratio
2.30
Shares on Issue (Fully Dilluted)
15m
HALO Sector
Industrials
Next Company Report Date
29-Feb-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 May 23 |
DurAVR Maintains Exceptional Results in New Patient Cohort
×
DurAVR Maintains Exceptional Results in New Patient Cohort |
31 May 23 |
Ceasing to be a substantial holder from MS
×
Ceasing to be a substantial holder from MS |
31 May 22 |
Successful Completion of Second First-In-Human Study
×
Successful Completion of Second First-In-Human Study |
31 March 22 |
Notice of AGM and Director Nominations
×
Notice of AGM and Director Nominations |
31 July 23 |
DurAVR first successful implantation Valve-in-Valve
×
DurAVR first successful implantation Valve-in-Valve |
31 January 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
30 May 23 |
Becoming a substantial holder from MS
×
Becoming a substantial holder from MS |
30 May 23 |
Notification of cessation of securities - AVR
×
Notification of cessation of securities - AVR |
30 May 23 |
Becoming a substantial holder from MUFG
×
Becoming a substantial holder from MUFG |
30 March 22 |
Application for quotation of securities - AVR
×
Application for quotation of securities - AVR |
30 March 22 |
Cleansing Notice
×
Cleansing Notice |
30 June 22 |
Notification of cessation of securities - AVR
×
Notification of cessation of securities - AVR |
30 June 22 |
Notification regarding unquoted securities - AVR
×
Notification regarding unquoted securities - AVR |
30 August 22 |
Application for quotation of securities - AVR
×
Application for quotation of securities - AVR |
30 August 22 |
Cleansing Notice
×
Cleansing Notice |
29 September 23 |
Application for quotation of securities - AVR
×
Application for quotation of securities - AVR |
29 September 23 |
Cleansing Notice
×
Cleansing Notice |
29 May 23 |
Notice of Annual General Meeting Withdrawal of Resolutions
×
Notice of Annual General Meeting Withdrawal of Resolutions |
29 May 23 |
AGM Chairman Address and CEO Presentation
×
AGM Chairman Address and CEO Presentation |
29 May 23 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
29 March 22 |
Notification of cessation of securities - AVR
×
Notification of cessation of securities - AVR |
29 June 23 |
Application for quotation of securities - AVR
×
Application for quotation of securities - AVR |
29 June 23 |
Cleansing Notice
×
Cleansing Notice |
29 December 21 |
Exercise of Underwritten Listed Options
×
Exercise of Underwritten Listed Options |
29 December 21 |
Appendix 2A
×
Appendix 2A |
29 December 21 |
Appendix 3G
×
Appendix 3G |
29 December 21 |
Cleansing Notice
×
Cleansing Notice |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.